Carl Goldfischer, Director at PONIARD PHARMACEUTICALS, INC. (PARD), bought 3,712 shares at $5.90 ($22K) on 2007-08-30, disclosed to the SEC on 2007-08-31.
Open-market purchase of $22k PARD by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $5.74 | 1 | $6 | 0.0% |
| 2 | $5.74 | 5 | $29 | 0.1% |
| 3 | $5.75 | 24 | $138 | 0.6% |
| 4 | $5.90 | 62 | $366 | 1.7% |
| 5 | $5.90 | 3,620 | $21K | 97.5% |
| Total | $5.90 avg | 3,712 |
| $22K |
| 100% |
| Filing → |
| CBAY | SELL | 2018-03-23 | $195K | — | Filing → |
| CBAY | SELL | 2017-11-06 | $156K | — | Filing → |
| ETRM | SELL | 2017-05-31 | $23K | — | Filing → |